{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:50:35Z","timestamp":1785916235025,"version":"3.56.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07137-1","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:26:06Z","timestamp":1785914766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epitranscriptomic imprints on glial cell polarization: METTL3\/IGF2BP2 axis as a driver of neurodegeneration in Alzheimer\u2019s disease"],"prefix":"10.1007","author":[{"family":"Neha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"7137_CR1","doi-asserted-by":"publisher","unstructured":"Akther M, Haque ME, Park J, Kang TB, Lee KH (2021) NLRP3 ubiquitination\u2014a new approach to target NLRP3 inflammasome activation. Int J Mol Sci 8780. https:\/\/doi.org\/10.3390\/ijms22168780","DOI":"10.3390\/ijms22168780"},{"key":"7137_CR2","doi-asserted-by":"publisher","unstructured":"Altmann A., Tian L., Henderson V.W., Greicius M.D., 2014. Alzheimer\u2019s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of neurology, 563\u2009\u2212\u200973. https:\/\/doi.org\/10.1002\/ana.24135","DOI":"10.1002\/ana.24135"},{"key":"7137_CR3","doi-asserted-by":"publisher","first-page":"594998","DOI":"10.3389\/fcell.2020.594998","volume":"8","author":"Y Ben Zablah","year":"2020","unstructured":"Ben Zablah Y, Merovitch N, Jia Z (2020) The role of ADF\/cofilin in synaptic physiology and Alzheimer\u2019s disease. Front Cell Dev Biology 8:594998. https:\/\/doi.org\/10.3389\/fcell.2020.594998","journal-title":"Front Cell Dev Biology"},{"key":"7137_CR4","doi-asserted-by":"publisher","first-page":"809433","DOI":"10.3389\/fnagi.2021.809433","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Chai Y, Fu Y, Wang Y, Zhang Y, Zhang X, Zhu L, Miao M, Yan T (2022) Salidroside ameliorates Alzheimer\u2019s disease by targeting NLRP3 inflammasome-mediated pyroptosis. Front Aging Neurosci 13:809433. https:\/\/doi.org\/10.3389\/fnagi.2021.809433","journal-title":"Front Aging Neurosci"},{"key":"7137_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/ijms25010111","volume":"25","author":"YY Cao","year":"2023","unstructured":"Cao YY, Wu LL, Li XN, Yuan YL, Zhao WW, Qi JX, Zhao XY, Ward N, Wang J (2023) Molecular mechanisms of AMPA receptor trafficking in the nervous system. Int J Mol Sci 25:111. https:\/\/doi.org\/10.3390\/ijms25010111","journal-title":"Int J Mol Sci"},{"key":"7137_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41419-023-06407-6","volume":"15","author":"F Cao","year":"2024","unstructured":"Cao F, Chen G, Xu Y, Wang X, Tang X, Zhang W, Song X, Yang X, Zeng W, Xie J (2024) METTL14 contributes to acute lung injury by stabilizing NLRP3 expression in an IGF2BP2-dependent manner. Cell Death Dis 15:43. https:\/\/doi.org\/10.1038\/s41419-023-06407-6","journal-title":"Cell Death Dis"},{"key":"7137_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox13010021","volume":"13","author":"S Chandran","year":"2023","unstructured":"Chandran S, Binninger D (2023) Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer\u2019s Disease. Antioxidants 13:21. https:\/\/doi.org\/10.3390\/antiox13010021","journal-title":"Antioxidants"},{"key":"7137_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38:1205\u20131235. https:\/\/doi.org\/10.1038\/aps.2017.28","journal-title":"Acta Pharmacol Sin"},{"key":"7137_CR8","doi-asserted-by":"publisher","unstructured":"Chen H., Xing H., Zhong C., Lin X., Chen R., Luo N., Chen L., Huang Y., 2024. METTL3 confers protection against mitochondrial dysfunction and cognitive impairment in an Alzheimer disease mouse model by upregulating Mfn2 via N6-methyladenosine modification. Journal of Neuropathology & Experimental Neurology, 606\u2009\u2212\u200914. https:\/\/doi.org\/10.1093\/jnen\/nlae010","DOI":"10.1093\/jnen\/nlae010"},{"key":"7137_CR10","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/S2214-109X(24)00264-X","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen S, Cao Z, Nandi A, Counts N, Jiao L, Prettner K, Kuhn M, Seligman B, Tortorice D, Vigo D, Wang C (2024) The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories. Lancet Global Health 12:1534\u20131543. https:\/\/doi.org\/10.1016\/S2214-109X(24)00264-X","journal-title":"Lancet Global Health"},{"key":"7137_CR11","doi-asserted-by":"publisher","first-page":"9036","DOI":"10.3390\/ijms21239036","volume":"21","author":"A Chiarini","year":"2020","unstructured":"Chiarini A, Armato U, Hu P, Dal Pra I (2020) Danger-sensing\/patten recognition receptors and neuroinflammation in Alzheimer\u2019s disease. Int J Mol Sci 21:9036. https:\/\/doi.org\/10.3390\/ijms21239036","journal-title":"Int J Mol Sci"},{"key":"7137_CR12","doi-asserted-by":"publisher","first-page":"943321","DOI":"10.3389\/fimmu.2022.943321","volume":"13","author":"Z Cui","year":"2022","unstructured":"Cui Z, Zhao X, Amevor FK, Du X, Wang Y, Li D, Shu G, Tian Y, Zhao X (2022) Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front Immunol 13:943321. https:\/\/doi.org\/10.3389\/fimmu.2022.943321","journal-title":"Front Immunol"},{"key":"7137_CR13","doi-asserted-by":"publisher","unstructured":"Das S, Li Z, Wachter A, Alla S, Noori A, Abdourahman A, Tamm JA, Woodbury ME, Talanian RV, Biber K, Karran EH (2024) Distinct transcriptomic responses to A\u03b2 plaques, neurofibrillary tangles, and APOE in Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia, pp 74\u201390. https:\/\/doi.org\/10.1002\/alz.13387","DOI":"10.1002\/alz.13387"},{"key":"7137_CR49","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1074\/jbc.M114.608018","volume":"290","author":"JS De Meabon","year":"2015","unstructured":"Meabon JS, De Laat R, Ieguchi K, Wiley JC, Hudson MP, Bothwell M (2015) LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments. J Biol Chem 290:9511\u20139520. https:\/\/doi.org\/10.1074\/jbc.M114.608018","journal-title":"J Biol Chem"},{"key":"7137_CR14","doi-asserted-by":"publisher","unstructured":"Deng Y., Zhu H., Xiao L., Liu C., Liu Y.L., Gao W., 2021. Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer\u2019s disease. Aging (Albany NY), 24086. https:\/\/doi.org\/10.18632\/aging.203652","DOI":"10.18632\/aging.203652"},{"key":"7137_CR15","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s12031-020-01555-2","volume":"70","author":"YK Dhuriya","year":"2020","unstructured":"Dhuriya YK, Sharma D (2020) Neuronal plasticity: neuronal organization is associated with neurological disorders. J Mol Neurosci 70:1684\u20131701. https:\/\/doi.org\/10.1007\/s12031-020-01555-2","journal-title":"J Mol Neurosci"},{"key":"7137_CR16","doi-asserted-by":"publisher","unstructured":"Diering GH, Huganir RL (2018) The AMPA receptor code of synaptic plasticity. Neuron 100:314\u2013329. https:\/\/doi.org\/10.1016\/j.neuron.2018.10.018","DOI":"10.1016\/j.neuron.2018.10.018"},{"key":"7137_CR65","doi-asserted-by":"publisher","unstructured":"Xia, Y., Huang, Y., Liu, Y., Zhang, X., Kang, H., Liu, Y., Yu, C., Gan, C. and Zhang, H., 2018. The roles of microglia and astrocytes in inflammasomes and neurological disorders. Neural Regeneration Research, 10-4103. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01574","DOI":"10.4103\/NRR.NRR-D-24-01574"},{"key":"7137_CR17","doi-asserted-by":"publisher","unstructured":"Gao S, Wang Y, Li X, Liang Y, Jin Z, Yang B, Yuan TF, Tian H, Peng B, Rao Y (2024) Dynamics of N6-methyladenosine modification during Alzheimer\u2019s disease development. Heliyon 10(6). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26911","DOI":"10.1016\/j.heliyon.2024.e26911"},{"key":"7137_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fnagi.2013.00098","volume":"5","author":"MO Grimm","year":"2013","unstructured":"Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, Hartmann T (2013) Neprilysin and A\u03b2 clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer\u2019s disease. Front Aging Neurosci 5:98. https:\/\/doi.org\/10.3389\/fnagi.2013.00098","journal-title":"Front Aging Neurosci"},{"key":"7137_CR19","doi-asserted-by":"publisher","unstructured":"Guan X, Zhang F, Zhang N, Li G, Yin F (2025) Roles of METTL3 and NLRP3 in pyroptosis and prospects in SCIRI. Front Immunol 1552704. https:\/\/doi.org\/10.3389\/fimmu.2025.1552704","DOI":"10.3389\/fimmu.2025.1552704"},{"key":"7137_CR20","doi-asserted-by":"publisher","first-page":"13641","DOI":"10.1096\/fj.202000826R","volume":"34","author":"A Guillemain","year":"2020","unstructured":"Guillemain A, Laouarem Y, Cobret L, \u0160tefok D, Chen W, Bloch S, Zahaf A, Blot L, Reverchon F, Normand T, Decoville M (2020) LINGO family receptors are differentially expressed in the mouse brain and form native multimeric complexes. FASEB J 34:13641\u201313653. https:\/\/doi.org\/10.1096\/fj.202000826R","journal-title":"FASEB J"},{"key":"7137_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fnins.2020.00098","volume":"14","author":"M Han","year":"2020","unstructured":"Han M, Liu Z, Xu Y, Liu X, Wang D, Li F, Wang Y, Bi J (2020) Abnormality of m6A mRNA methylation is involved in Alzheimer\u2019s disease. Front NeuroSci 14:98. https:\/\/doi.org\/10.3389\/fnins.2020.00098","journal-title":"Front NeuroSci"},{"key":"7137_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ibra.12183","volume":"10","author":"MATS Hashmi","year":"2024","unstructured":"Hashmi MATS, Fatima H, Ahmad S, Rehman A, Safdar F (2024) The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies. ibrain 10:395\u2013426. https:\/\/doi.org\/10.1002\/ibra.12183","journal-title":"ibrain"},{"key":"7137_CR23","doi-asserted-by":"publisher","first-page":"105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C (2021) m6A RNA methylation: from mechanisms to therapeutic potential. EMBO J 40:105977. https:\/\/doi.org\/10.15252\/embj.2020105977","journal-title":"EMBO J"},{"key":"7137_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493:674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"key":"7137_CR25","doi-asserted-by":"publisher","unstructured":"Henstridge CM, Hyman BT, Spires-Jones TL (2019) Beyond the neuron\u2013cellular interactions early in Alzheimer disease pathogenesis. Nat Rev Neurosci 94\u2013108. https:\/\/doi.org\/10.1038\/s41583-018-0113-1","DOI":"10.1038\/s41583-018-0113-1"},{"key":"7137_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, Zhao BS, Mesquita A, Liu C, Yuan CL, Hu YC (2018) Recognition of RNA N 6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20:285\u2013295. https:\/\/doi.org\/10.1038\/s41556-018-0045-z","journal-title":"Nat Cell Biol"},{"key":"7137_CR26","doi-asserted-by":"publisher","unstructured":"Huang H., Camats-Perna J., Medeiros R., Anggono V., Widagdo J., 2020. Altered expression of the m6A methyltransferase METTL3 in Alzheimer\u2019s disease. Eneuro, 7(5). https:\/\/doi.org\/10.1523\/ENEURO.0125-20.2020","DOI":"10.1523\/ENEURO.0125-20.2020"},{"key":"7137_CR81","first-page":"150067","volume":"21","author":"S Hui","year":"2025","unstructured":"Hui S, Long Y, Zhu L, Shi W, Zheng Q, Liang L (2025 Nov) IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer\u2019s disease. Brain Res 21:150067","journal-title":"Brain Res"},{"key":"7137_CR29","doi-asserted-by":"publisher","first-page":"9475","DOI":"10.3390\/ijms25179475","volume":"25","author":"M Ianni","year":"2024","unstructured":"Ianni M, Corraliza-Gomez M, Costa-Coelho T, Ferreira-Manso M, Inteiro-Oliveira S, Alem\u00e3n-Serrano N, Sebasti\u00e3o AM, Garcia G, Di\u00f3genes MJ, Brites D (2024) Spatiotemporal dysregulation of neuron\u2013glia related genes and pro-\/anti-inflammatory miRNAs in the 5xFAD mouse model of Alzheimer\u2019s disease. Int J Mol Sci 25:9475. https:\/\/doi.org\/10.3390\/ijms25179475","journal-title":"Int J Mol Sci"},{"key":"7137_CR30","doi-asserted-by":"publisher","unstructured":"Islam R., Choudhary H.H., Zhang F., Mehta H., Yoshida J., Thomas A.J., Hanafy K., 2025. Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, A\u03b2 phagocytosis, neuronal damage, and cell survival in Alzheimer\u2019s disease. Scientific reports, 11368. https:\/\/doi.org\/10.1038\/s41598-025-96456-y","DOI":"10.1038\/s41598-025-96456-y"},{"key":"7137_CR31","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1091\/mbc.E19-03-0183","volume":"30","author":"M Iwata","year":"2019","unstructured":"Iwata M, Watanabe S, Yamane A, Miyasaka T, Misonou H (2019) Regulatory mechanisms for the axonal localization of tau protein in neurons. Mol Biol Cell 30:2441\u20132457. https:\/\/doi.org\/10.1091\/mbc.E19-03-0183","journal-title":"Mol Biol Cell"},{"key":"7137_CR33","doi-asserted-by":"publisher","first-page":"70121","DOI":"10.1002\/iid3.70121","volume":"13","author":"W Jingrui","year":"2025","unstructured":"Jingrui W, Haihui Y, Jinjin Y, Le F (2025) IGF2BP2 Regulates the Progression of Alzheimer\u2019s Disease Through m6A-Mediated NLRP3 Inflammasome. Immun Inflamm Dis 13:70121. https:\/\/doi.org\/10.1002\/iid3.70121","journal-title":"Immun Inflamm Dis"},{"key":"7137_CR50","doi-asserted-by":"publisher","unstructured":"Miller, C., Ealy, A., Gregory, A., Janarthanam, C., Albers, W., Richardson, G., Jin, H., Zenitsky, G., Anantharam, V., Kanthasamy, A. and Kanthasamy, A.G., 2025. Pathological \u03b1-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia. Cell reports, 44. https:\/\/doi.org\/10.1016\/j.celrep.2025.115618","DOI":"10.1016\/j.celrep.2025.115618"},{"key":"7137_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/v16040601","volume":"16","author":"I Karandashov","year":"2024","unstructured":"Karandashov I, Kachanov A, Dukich M, Ponomareva N, Brezgin S, Lukashev A, Pokrovsky VS, Chulanov V, Kostyusheva A, Kostyushev D (2024) m6A methylation in regulation of antiviral innate immunity. Viruses 16:601. https:\/\/doi.org\/10.3390\/v16040601","journal-title":"Viruses"},{"key":"7137_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RS, Kanneganti TD (2020) Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol 38:567\u2013595. https:\/\/doi.org\/10.1146\/annurev-immunol-073119-095439","journal-title":"Annu Rev Immunol"},{"key":"7137_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","volume":"7","author":"T Kimura","year":"2014","unstructured":"Kimura T, Ishiguro K, Hisanaga SI (2014) Physiological and pathological phosphorylation of tau by Cdk5. Front Mol Neurosci 7:65. https:\/\/doi.org\/10.3389\/fnmol.2014.00065","journal-title":"Front Mol Neurosci"},{"key":"7137_CR39","unstructured":"Kirynovich, L., 2024. The role of the m6A pathway in the regulation and disorders of cognitive functions. http:\/\/hdl.handle.net\/20.500.11956\/194351"},{"key":"7137_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR (2023) Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun 11:42. https:\/\/doi.org\/10.1186\/s40478-023-01526-9","journal-title":"Acta Neuropathol Commun"},{"key":"7137_CR37","doi-asserted-by":"publisher","unstructured":"Kim, C., Kang, D., Lee, E.K. and Lee, J.S., 2017. Long noncoding RNAs and RNA-binding proteins in oxidative stress, cellular senescence, and age\u2010related diseases. Oxidative Medicine and Cellular Longevity, 2017, 2062384. https:\/\/doi.org\/10.1155\/2017\/2062384","DOI":"10.1155\/2017\/2062384"},{"key":"7137_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.18632\/aging.203652","volume":"18","author":"Q Li","year":"2021","unstructured":"Li Q, Wen S, Ye W, Zhao S, Liu X (2021) The potential roles of m6A modification in regulating the inflammatory response in microglia. J Neuroinflamm 18:149. https:\/\/doi.org\/10.18632\/aging.203652","journal-title":"J Neuroinflamm"},{"key":"7137_CR43","doi-asserted-by":"publisher","first-page":"1284214","DOI":"10.3389\/fnagi.2023.1284214","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, Li YJ, Zhu ZQ (2023) To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis. Front Aging Neurosci 15:1284214. https:\/\/doi.org\/10.3389\/fnagi.2023.1284214","journal-title":"Front Aging Neurosci"},{"key":"7137_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/biology13060412","volume":"13","author":"X Li","year":"2024","unstructured":"Li X, Han Z, Li H (2024) Hif3\u03b1 Plays Key Roles in the Progression of Alzheimer\u2019s Disease Caused by Circadian Rhythm Disruption through Regulating the m6A\/KDM3A\/TGF-\u03b21 Axis. Biology 13:412. https:\/\/doi.org\/10.3390\/biology13060412","journal-title":"Biology"},{"key":"7137_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40035-023-00341-5","volume":"12","author":"Y Lu","year":"2023","unstructured":"Lu Y, Bu FQ, Wang F, Liu L, Zhang S, Wang G, Hu XY (2023) Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction. Translational Neurodegeneration 12:9. https:\/\/doi.org\/10.1186\/s40035-023-00341-5","journal-title":"Translational Neurodegeneration"},{"key":"7137_CR45","doi-asserted-by":"publisher","first-page":"28596","DOI":"10.1074\/jbc.R115.652750","volume":"290","author":"MP Lussier","year":"2015","unstructured":"Lussier MP, Sanz-Clemente A, Roche KW (2015) Dynamic regulation of N-methyl-d-aspartate (NMDA) and \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by posttranslational modifications. J Biol Chem 290:28596\u201328603.","journal-title":"J Biol Chem"},{"key":"7137_CR46","doi-asserted-by":"publisher","first-page":"739201","DOI":"10.3389\/fnins.2022.739201","volume":"16","author":"Z Lv","year":"2022","unstructured":"Lv Z, Xu T, Li R, Zheng D, Li Y, Li W, Yang Y, Hao Y (2022) Downregulation of m6A Methyltransferase in the Hippocampus of Tyrobp\u2013\/\u2013Mice and Implications for Learning and Memory Deficits. Front NeuroSci 16:739201. https:\/\/doi.org\/10.3389\/fnins.2022.739201","journal-title":"Front NeuroSci"},{"key":"7137_CR47","doi-asserted-by":"publisher","first-page":"671932","DOI":"10.3389\/fncel.2021.671932","volume":"15","author":"J Mathoux","year":"2021","unstructured":"Mathoux J, Henshall DC, Brennan GP (2021) Regulatory mechanisms of the RNA modification m6A and significance in brain function in health and disease. Front Cell Neurosci 15:671932. https:\/\/doi.org\/10.3389\/fncel.2021.671932","journal-title":"Front Cell Neurosci"},{"key":"7137_CR48","doi-asserted-by":"publisher","unstructured":"Mathys H., Boix C.A., Akay L.A., Xia Z., Davila-Velderrain J., Ng A.P., Jiang X., Abdelhady G., Galani K., Mantero J., Band N., 2024. Single-cell multiregion dissection of Alzheimer\u2019s disease, 858\u2009\u2212\u200968. https:\/\/doi.org\/10.1038\/s41586-024-07606-7","DOI":"10.1038\/s41586-024-07606-7"},{"key":"7137_CR51","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1111\/bph.14593","volume":"176","author":"NN Nalivaeva","year":"2019","unstructured":"Nalivaeva NN, Turner AJ (2019) Targeting amyloid clearance in Alzheimer\u2019s disease as a therapeutic strategy. Br J Pharmacol 176:3447\u20133463. https:\/\/doi.org\/10.1111\/bph.14593","journal-title":"Br J Pharmacol"},{"key":"7137_CR52","doi-asserted-by":"publisher","unstructured":"Neu S.C., Pa J., Kukull W., Beekly D., Kuzma A., Gangadharan P., Wang L.S., Romero K., Arneric S.P., Redolfi A., Orlandi D., 2017. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA neurology, 1178-89. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2188","DOI":"10.1001\/jamaneurol.2017.2188"},{"key":"7137_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/biom14020173","volume":"14","author":"DH O\u2019Day","year":"2024","unstructured":"O\u2019Day DH (2024) The complex interplay between toxic hallmark proteins, calmodulin-binding proteins, ion channels, and receptors involved in calcium dyshomeostasis in neurodegeneration. Biomolecules 14:173. https:\/\/doi.org\/10.3390\/biom14020173","journal-title":"Biomolecules"},{"key":"7137_CR54","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.3390\/ijms26094209","volume":"26","author":"T Ponce-Lopez","year":"2025","unstructured":"Ponce-Lopez T (2025) Peripheral Inflammation and Insulin Resistance: Their Impact on Blood\u2013Brain Barrier Integrity and Glia Activation in Alzheimer\u2019s Disease. Int J Mol Sci 26:4209. https:\/\/doi.org\/10.3390\/ijms26094209","journal-title":"Int J Mol Sci"},{"key":"7137_CR55","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"7137_CR56","doi-asserted-by":"publisher","unstructured":"Sadick J.S., O\u2019Dea M.R., Hasel P., Dykstra T., Faustin A., Liddelow S.A., 2022. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron, 1788\u2009\u2212\u2009805. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.008","DOI":"10.1016\/j.neuron.2022.03.008"},{"key":"7137_CR57","doi-asserted-by":"publisher","unstructured":"Santello M., Toni N., Volterra A., 2019. Astrocyte function from information processing to cognition and cognitive impairment. Nature neuroscience, 154\u2009\u2212\u200966. https:\/\/doi.org\/10.1038\/s41593-018-0325-8","DOI":"10.1038\/s41593-018-0325-8"},{"key":"7137_CR58","doi-asserted-by":"publisher","unstructured":"Shafik A.M., Zhang F., Guo Z., Dai Q., Pajdzik K., Li Y., Kang Y., Yao B., Wu H., He C., Allen E.G., 2021. N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer\u2019s disease. Genome biology, 17. https:\/\/doi.org\/10.1186\/s13059-020-02249-z","DOI":"10.1186\/s13059-020-02249-z"},{"key":"7137_CR59","doi-asserted-by":"publisher","unstructured":"Smith A.M., Davey K., Tsartsalis S., Khozoie C., Fancy N., Tang S.S., Liaptsi E., Weinert M., McGarry A., Muirhead R.C., Gentleman S., 2022. Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u2019s pathology. Acta neuropathologica, 75\u201391. https:\/\/doi.org\/10.1007\/s00401-021-02372-6","DOI":"10.1007\/s00401-021-02372-6"},{"key":"7137_CR60","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/biom13040664","volume":"13","author":"X Su","year":"2023","unstructured":"Su X, Qu Y, Mu D (2023) The regulatory network of METTL3 in the nervous system: diagnostic biomarkers and therapeutic targets. Biomolecules 13:664. https:\/\/doi.org\/10.3390\/biom13040664","journal-title":"Biomolecules"},{"key":"7137_CR61","doi-asserted-by":"publisher","unstructured":"Thirumalai S, Patani R, Hung C (2024) Therapeutic potential of APP antisense oligonucleotides for Alzheimer\u2019s disease and down syndrome-related Alzheimer\u2019s disease. Mol neurodegeneration 19(57). https:\/\/doi.org\/10.1186\/s13024-024-00745-5","DOI":"10.1186\/s13024-024-00745-5"},{"key":"7137_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40779-016-0095-0","volume":"3","author":"H Wang","year":"2016","unstructured":"Wang H, Peng RY (2016) Basic roles of key molecules connected with NMDAR signaling pathway on regulating learning and memory and synaptic plasticity. Military Med Res 3:26. https:\/\/doi.org\/10.1186\/s40779-016-0095-0","journal-title":"Military Med Res"},{"key":"7137_CR28","doi-asserted-by":"publisher","unstructured":"Huang, Y., Chen, Y., He, Z., Lu, W., Lai, H., Wang, Y. and Wang, J., 2025. MicroRNA and Alzheimer\u2019s disease: Diagnostic biomarkers and potential therapeutic targets. Neural Regeneration Research, 10-4103. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00002","DOI":"10.4103\/NRR.NRR-D-25-00002"},{"key":"7137_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","volume":"115","author":"S Wang","year":"2010","unstructured":"Wang S, Wang R, Chen L, Bennett DA, Dickson DW, Wang DS (2010) Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin\u2010converting enzyme in prospectively studied elderly and Alzheimer\u2019s brain. J Neurochem 115:47\u201357. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06899.x","journal-title":"J Neurochem"},{"key":"7137_CR64","doi-asserted-by":"publisher","first-page":"1166831","DOI":"10.3389\/fgene.2023.1166831","volume":"14","author":"L Xia","year":"2023","unstructured":"Xia L, Zhang F, Li Y, Mo Y, Zhang L, Li Q, Luo M, Hou X, Du Z, Deng J, Hao E (2023) A new perspective on Alzheimer\u2019s disease: m6A modification. Front Genet 14:1166831. https:\/\/doi.org\/10.3389\/fgene.2023.1166831","journal-title":"Front Genet"},{"key":"7137_CR66","doi-asserted-by":"publisher","first-page":"1325530","DOI":"10.3389\/fimmu.2023.1325530","volume":"14","author":"Y Ye","year":"2024","unstructured":"Ye Y, Gao M, Shi W, Gao Y, Li Y, Yang W, Zheng X, Lu X (2024) The immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles in Alzheimer\u2019s disease. Front Immunol 14:1325530. https:\/\/doi.org\/10.3389\/fimmu.2023.1325530","journal-title":"Front Immunol"},{"key":"7137_CR67","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1038\/s41467-025-59117-2","volume":"16","author":"YP Yen","year":"2025","unstructured":"Yen YP, Lung TH, Liau ES, Wu CC, Huang GL, Hsu FY, Chang M, Yang ZD, Huang CY, Zheng Z, Zhao W (2025) The motor neuron m6A repertoire governs neuronal homeostasis and FTO inhibition mitigates ALS symptom manifestation. Nat Commun 16:4063. https:\/\/doi.org\/10.1038\/s41467-025-59117-2","journal-title":"Nat Commun"},{"key":"7137_CR68","doi-asserted-by":"publisher","first-page":"3002017","DOI":"10.1371\/journal.pbio.3002017","volume":"21","author":"H Yin","year":"2023","unstructured":"Yin H, Ju Z, Zheng M, Zhang X, Zuo W, Wang Y, Ding X, Zhang X, Peng Y, Li J, Yang A (2023) Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer\u2019s disease pathology in mice. PLoS Biol 21:3002017. https:\/\/doi.org\/10.1371\/journal.pbio.3002017","journal-title":"PLoS Biol"},{"key":"7137_CR32","doi-asserted-by":"publisher","unstructured":"Jiang, L., Li, X., Wang, S., Yuan, Z. and Cheng, J., 2022. The role and regulatory mechanism of m6A methylation in the nervous system. Frontiers in Genetics, 962774. https:\/\/doi.org\/10.3389\/fgene.2022.962774","DOI":"10.3389\/fgene.2022.962774"},{"key":"7137_CR71","doi-asserted-by":"publisher","unstructured":"Zhang, J., Ma, W., Liu, R., Li, X., Yuan, Z. and Cheng, J., 2025. Neuromodulatory role and therapeutic potential of N6-methyladenosine RNA methylation in neurodegenerative diseases. Neural Regeneration Research, 10-4103. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01648","DOI":"10.4103\/NRR.NRR-D-24-01648"},{"key":"7137_CR80","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1111\/febs.16939","volume":"291","author":"J \u017bukowska","year":"2024","unstructured":"\u017bukowska J, Moss SJ, Subramanian V, Acharya KR (2024) Molecular basis of selective amyloid-\u03b2 degrading enzymes in Alzheimer\u2019s disease. FEBS J 291:2999\u20133029. https:\/\/doi.org\/10.1111\/febs.16939","journal-title":"FEBS J"},{"key":"7137_CR73","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1523\/JNEUROSCI.0340-17.2017","volume":"37","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wang Z, Cai F, Zhang M, Wu Y, Zhang J, Song W (2017) BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer\u2019s pathogenesis. J Neurosci 37:6915\u20136925. https:\/\/doi.org\/10.1523\/JNEUROSCI.0340-17.2017","journal-title":"J Neurosci"},{"key":"7137_CR70","doi-asserted-by":"publisher","unstructured":"Zhang Z., Wang M., Xie D., Huang Z., Zhang L., Yang Y., Ma D., Li W., Zhou Q., Yang Y.G., Wang X.J., 2018. METTL3-mediated N 6-methyladenosine mRNA modification enhances long-term memory consolidation. Cell research, 1050-61. https:\/\/doi.org\/10.1038\/s41422-018-0092-9","DOI":"10.1038\/s41422-018-0092-9"},{"key":"7137_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","volume":"19","author":"L Zhang","year":"2020","unstructured":"Zhang L, Hou C, Chen C, Guo Y, Yuan W, Yin D, Liu J, Sun Z (2020) The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs. Mol Cancer 19:105. https:\/\/doi.org\/10.1186\/s12943-020-01224-3","journal-title":"Mol Cancer"},{"key":"7137_CR74","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao Y, Zhang J, Yang G (2020) Mechanisms of NLRP3 inflammasome activation: its role in the treatment of Alzheimer\u2019s disease. Neurochem Res 45:2560\u20132572. https:\/\/doi.org\/10.1007\/s11064-020-03121-z","journal-title":"Neurochem Res"},{"key":"7137_CR69","doi-asserted-by":"publisher","unstructured":"Zhang L., Wei J., Zou Z., He C.,2026. RNA modification systems as therapeutic targets. Nature Reviews Drug Discovery, 59\u201378. https:\/\/doi.org\/10.1038\/s41573-025-01280-8","DOI":"10.1038\/s41573-025-01280-8"},{"key":"7137_CR34","doi-asserted-by":"publisher","unstructured":"Kang, K., Bai, J., Zhong, S., Zhang, R., Zhang, X., Xu, Y., Zhao, M., Zhao, C. and Zhou, Z., 2022. Down-Regulation of Insulin Like Growth Factor 1 Involved in Alzheimer\u2019s Disease via MAPK, Ras, and FoxO Signaling Pathways. Oxidative Medicine and Cellular Longevity, 2022, 8169981. https:\/\/doi.org\/10.1155\/2022\/8169981","DOI":"10.1155\/2022\/8169981"},{"key":"7137_CR76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13024-021-00484-x","volume":"16","author":"F Zhao","year":"2021","unstructured":"Zhao F, Xu Y, Gao S, Qin L, Austria Q, Siedlak SL, Pajdzik K, Dai Q, He C, Wang W, O\u2019Donnell JM (2021) METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer\u2019s disease through aberrant cell cycle events. Mol neurodegeneration 16:70. https:\/\/doi.org\/10.1186\/s13024-021-00484-x","journal-title":"Mol neurodegeneration"},{"key":"7137_CR78","doi-asserted-by":"publisher","unstructured":"Zhu M.J., Zhang L., Wang C.P., 2024. Copper overload promotes \u03b2-amyloid induced NLRP3\/caspase-1\/GSDMD-mediated pyroptosis in Alzheimer\u2019s disease. Journal of Integrative Neuroscience, 194. https:\/\/doi.org\/10.31083\/j.jin2310194","DOI":"10.31083\/j.jin2310194"},{"key":"7137_CR79","doi-asserted-by":"publisher","first-page":"105964","DOI":"10.1016\/j.neuint.2025.105964","volume":"186","author":"L Zhu","year":"2025","unstructured":"Zhu L, Liu C, Wang Y, Zhu X, Wu L, Chen L, Zhou J, Wang F (2025) METTL3\/IGF2BP2\/I\u03baB\u03b1 axis participates in neuroinflammation in Alzheimer\u2019s disease by regulating M1\/M2 polarization of microglia. Neurochem Int 186:105964. https:\/\/doi.org\/10.1016\/j.neuint.2025.105964","journal-title":"Neurochem Int"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07137-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:26:07Z","timestamp":1785914767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07137-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":79,"alternative-id":["7137"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07137-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest to declare.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}